NIH Grants $2 Million for Novel Autism Spectrum Disorder Diagnostic Assay
NIH small business technology transfer grant supports ‘game-changing’ epigenetic ASD diagnostic test.
Read MoreSearch Results for: genetic testing
Signatera Assay Selected for Study of Adjuvant Therapy for Non-Small Cell Lung Cancer
Partners to conduct first study using ctDNA-based minimal residual disease assessment for immunotherapy in the adjuvant non-small cell lung cancer setting.
Read More
FDA Approves Grifols ID CORE XT Test
The molecular red blood cell typing test offers the shortest time to reportable results for US hospitals, reference labs, and blood centers.
Read More
Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer
FDA approval allows use of the Therascreen EGFR RGQ PCR kit as a companion diagnostic for Pfizer’s Vizimpro (dacomitinib) in patients with non-small cell lung cancer.
Read More
Earlier Autism Diagnosis Possible Based on Metabolic Biomarkers
New biomarkers detected in a 1,100-subject study accurately identify specific subtypes of ASD related to abnormalities in metabolizing certain amino acids important to typical neurodevelopment.
Read More